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Susy Yusung1* and Jonathan Braun2Abstract
Preventive immunization has provided one of the major advances in population health during the past century.
However, a surprising cultural phenomenon is the emergence of concerns about immunization safety, in part due
to prominently controversial biomedical studies. One ongoing theoretical safety concern is the possibility of human
molecular mimicry by measles, mumps, rubella (MMR) antigens. The study of Polymeros et al. in this BMC Medicine
presents a systematic evaluation and refutation of this safety concern. This provides significant new scientific
evidence in support of the safety of pediatric vaccines, which will inform the ongoing policy and cultural
understanding of this important public health measure.
Please see related research article: http://www.biomedcentral.com/1741-7015/12/139/abstract.
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Measles virus is a highly contagious organism that can
cause multiple organ system complications and even
death. Introduction of the measles, mumps, rubella
(MMR) vaccine in the 1970s has saved innumerable
lives and attenuated severe morbidities globally. Despite
these remarkable gains, a claim emerged in the 1990s
which associated MMR vaccine with colitis and autism
spectrum disorders [1-4]. These association studies have
been recognized as methodologically flawed and in some
instances factually erroneous by the scientific and medical
communities [5]. However, doubt and even outright rejec-
tion of the vaccine’s safety still linger in various niches of
our society. These concerns have also reverberated in
the inflammatory bowel disease (IBD) community, in
part related to the publication of a study series implying
measles infection or vaccination with the live attenuated
virus mediate pathogenesis of Crohn’s disease (CD) [3,4,6].
Despite recognition that these studies were flawed in
methodology and hypothesis, they continue to provoke
much debate and inquiry into the role of measles virus
in the pathogenesis of IBD.* Correspondence: syusung@labiomed.org
1Department of Pediatrics, Harbor-UCLA Medical Center, 1000 W Carson St,
Torrance, CA 90502, USA
Full list of author information is available at the end of the article
© 2014 Yusung and Braun; licensee BioMed C
Creative Commons Attribution License (http:/
distribution, and reproduction in any medium
Domain Dedication waiver (http://creativecom
article, unless otherwise stated.Biologic context
Exposure to environmental antigens has long been sus-
pected to induce development of IBD in genetically
susceptible individuals. The ease of transmission and
pervasiveness of certain infectious organisms makes
the possibility of micro-organisms as antigenic triggers
of IBD into a tantalizing hypothesis. The discovery that
certain bacterial communities instigate inflammation of the
gut mucosa further intensified research of the microbiome
and simultaneously heightened awareness of elegant mech-
anisms by which viruses may serve as potential regulators
of gut mucosal inflammation [7]. In this context, a number
of viruses have been studied in association with human
CD - measles virus being one of the most commonly stud-
ied, preceded by cytomegalovirus and Epstein-Barr virus [8].
Several groups have investigated the plausible link be-
tween measles and IBD either through epidemiological
studies or biological analysis of tissue specimens. A study
published in 1995 first suggested that recipients of measles
vaccination had a three-fold increased risk of developing
CD and ulcerative colitis (UC) compared to unvaccinated
controls; however, this study was found to be limited
by methodological flaws and could not be validated [6,9].
Carefully designed studies thereafter demonstrated no
increased risk of CD in children vaccinated with MMR
[10,11]. Studies also comparing the frequency of measles
seropositivity in CD, UC and healthy populations foundentral Ltd. This is an Open Access article distributed under the terms of the
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In addition to these epidemiological studies, efforts have
been made to detect the presence of persistent measles
virus in tissue or serum samples from IBD patients using
PCR and immunohistochemical techniques. Results of
those immunohistochemical studies have been discordant
and contradictory [2,14], while the highly sensitive reverse
PCR method failed to detect any measles virus genome in
the intestinal tissues of CD patients [15-17]. In light of
these studies, several investigators have proposed a
‘measles related antigen’ in the human intestine which
shares identical epitopes with the measles virus and in-
duces immune reactivity through mechanisms of mo-
lecular mimicry [18-20].
In a study published in BMC Medicine, Polymeros et al.
[21] revisit the issue of measles-induced molecular mim-
icry as a mechanism which directs immune dysregulation
in CD. Firstly, this study is distinguishable from prior
studies by virtue of combined employment of experi-
mental immunologic data, bioinformatics, and detailed
molecular analysis of measles virus and human anti-
gens. Results from prior immunological studies have
demonstrated the development of antibodies against
HEMA and VGLF antigens following vaccination, iso-
lating these viral proteins as candidates for intestinal
antigen mimicry. The antigenic potential of HEMA
and VGLF epitopes are verified using prediction algo-
rithms and, subsequently, human intestinal proteins
which share these antigenic epitopes are identified and
analyzed as potential viral mimic candidates. Thus, the
utilization of technically validated methods and algo-
rithms serve as platforms for identification of candi-
date mimic proteins.
The paper identifies several candidate intestinal peptides
as potential measles virus antigen mimics. Changes in the
expression of some of the peptides, such as intestinal fatty
acid binding protein and sucrase isomaltase, have been
previously associated with intestinal inflammation in CD
patients. Another protein TOG, had been previously iden-
tified as sharing sequence analogue with Mycobacterium
avium paratuberculosis (MAP), and antibodies reactive to
this protein were found in both CD and healthy controls
[22]. Although these intestinal proteins appear to be viable
measles mimic candidates, no significant differences in
reactivity to any of these antigens were found among CD,
UC and healthy controls. Moreover, there were no signifi-
cant differences in reactivity to highly antigenic epitopes
of HEMA or VGLF among CD, UC and healthy individ-
uals. These results are in contrast to previous studies by
the present investigators, which found cross-reactivity be-
tween two sets of MAP and human intestinal peptides al-
though the observed cross reactivity was well within the
random rates predicted for heterologous peptides. In com-
parison, the lack of any cross reactivity between measlesand human intestinal peptides reinforces the high unlikeli-
hood of the measles virus having a role in CD pathogen-
icity via the mechanism of molecular mimicry.
Conclusions
At a biologic level, the present study of Polymeros et al.
thus is a fresh test of the hypothesis of microbial mo-
lecular mimicry in the pathogenesis of IBD, and provides
thoughtful and fastidious evidence against this hypoth-
esis. As we have noted, molecular mimicry is the puta-
tive link of concern between MMR vaccine and IBD risk.
Accordingly, at the level of public safety and policy, this
paper provides important new evidence against this link.
This carefully performed study should be an important
new reassurance to concerned families and medical care-
givers on the safety of the MMR vaccine with respect to
IBD susceptibility.
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